SecBot SecBot
SECBOTREPLAY Home › Report › VNDA

VNDA · State Street 5% passive stake

Vanda Pharmaceuticals Inc. · SC 13G filed Nov 10, 2026 at 09:33 ET

At the news

NEUTRALIMPACT 3/10

SC 13G filed Nov 10, 2026 at 09:33 ET

State Street Corporation filed a Schedule 13G disclosing a 5.0% passive stake in Vanda Pharmaceuticals as of September 30, 2026, with 3,010,531 shares held. This is a new filing by State Street, adding to existing institutional interest from BlackRock (5.9%) and Millennium Management (7.0%). The passive filing indicates no activist intent, but the presence of three large asset managers with 5%+ stakes signals notable institutional conviction in the company.

  • State Street Corp filed a new Schedule 13G disclosing a 5.0% passive stake in Vanda Pharmaceuticals
  • State Street holds 3,010,531 shares as of September 30, 2026
  • The filing certifies passive intent under Rule 13d-1(b), with no control or influence purpose
  • State Street joins BlackRock (5.9%) and Millennium Management (7.0%) as 5%+ holders

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access